221 related articles for article (PubMed ID: 20082715)
1. The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease.
Kandil TS; Mousa AA; El-Gendy AA; Abbas AM
BMC Gastroenterol; 2010 Jan; 10():7. PubMed ID: 20082715
[TBL] [Abstract][Full Text] [Related]
2. Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of Gastroesophageal Reflux Disease Symptoms: A Clinical Trial.
Malekpour H; Noori A; Abdi S; Abbasinazari M; Mahboubi A; Ghamsari MA
Turk J Gastroenterol; 2023 Dec; 34(12):1206-1211. PubMed ID: 37768310
[TBL] [Abstract][Full Text] [Related]
3. Melatonin for the treatment of gastroesophageal reflux disease.
Werbach MR
Altern Ther Health Med; 2008; 14(4):54-8. PubMed ID: 18616070
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
[TBL] [Abstract][Full Text] [Related]
5. Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.
Poelmans J; Feenstra L; Tack J
Dig Dis Sci; 2006 Feb; 51(2):282-8. PubMed ID: 16534670
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
9. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
10. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
12. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
Spechler SJ; Hunter JG; Jones KM; Lee R; Smith BR; Mashimo H; Sanchez VM; Dunbar KB; Pham TH; Murthy UK; Kim T; Jackson CS; Wallen JM; von Rosenvinge EC; Pearl JP; Laine L; Kim AW; Kaz AM; Tatum RP; Gellad ZF; Lagoo-Deenadayalan S; Rubenstein JH; Ghaferi AA; Lo WK; Fernando RS; Chan BS; Paski SC; Provenzale D; Castell DO; Lieberman D; Souza RF; Chey WD; Warren SR; Davis-Karim A; Melton SD; Genta RM; Serpi T; Biswas K; Huang GD
N Engl J Med; 2019 Oct; 381(16):1513-1523. PubMed ID: 31618539
[TBL] [Abstract][Full Text] [Related]
13. Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.
Walker D; Ng Kwet Shing R; Jones D; Gruss HJ; Reguła J
PLoS One; 2015; 10(2):e0116308. PubMed ID: 25706883
[TBL] [Abstract][Full Text] [Related]
14. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole.
Pereira Rde S
J Pineal Res; 2006 Oct; 41(3):195-200. PubMed ID: 16948779
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
[TBL] [Abstract][Full Text] [Related]
16. Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.
Bestebreurtje P; de Koning BAE; Roeleveld N; Knibbe CAJ; Tibboel D; van Groen B; van de Ven CP; Plötz FB; de Wildt SN
Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):635-643. PubMed ID: 32594305
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.
Sandur V; Murugesh M; Banait V; Rathi PM; Bhatia SJ; Joshi JM; Kate A
J Postgrad Med; 2014; 60(3):282-6. PubMed ID: 25121368
[TBL] [Abstract][Full Text] [Related]
18. [Significance of PPI-test in the diagnosis of GERD].
Takahashi M; Nishiki R; Ichimura H; Takada H; Kuwayama H
Nihon Rinsho; 2004 Aug; 62(8):1465-74. PubMed ID: 15344536
[TBL] [Abstract][Full Text] [Related]
19. Combination drug therapy for gastroesophageal reflux disease.
Cross LB; Justice LN
Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
[TBL] [Abstract][Full Text] [Related]
20. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
Dobrzycki S; Baniukiewicz A; Korecki J; Bachórzewska-Gajewska H; Prokopczuk P; Musial WJ; Kamiński KA; Dabrowski A
Int J Cardiol; 2005 Sep; 104(1):67-72. PubMed ID: 16137512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
